AMISULPRIDE SCP amisulpride 400 mg uncoated tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

amisulpride, Quantity: 400 mg

Available from:

Southern Cross Pharma Pty Ltd

INN (International Name):

Amisulpride

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: lactose monohydrate; magnesium stearate; sodium starch glycollate type A; microcrystalline cellulose; hypromellose

Administration route:

Oral

Units in package:

60, 90, 30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Product summary:

Visual Identification: White, biconvex, capsule shaped tablets, scored on both sides with dimensions 19 x 10 mm; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-01-29